Evaluation of a Mobile Application to Facilitate the Interpretation of Spirometry by Family Physicians and Residents

NCT03206606 | Completed

• 1 other identifier: SPIRO-MD Residents
• Study Type: observational
• Target: 104
• Locations: 1 country
• Sites: 8

Brief Summary

Problematic: Spirometry is used to objectify the obstructive syndrome defining chronic obstructive pulmonary disease (COPD). However, this test remains underused in the primary care. The tools available for its interpretation are little used and the existence of several decision algorithms can create confusion during the diagnosis. Principal objective: To evaluate the impact of a mobile application (SPIRO©) on medical practice (interpretation and prescription of spirometry) of family physicians and family medicine residents working in family medicine units (FMU) in Quebec affiliated with Laval University. Secondary objective : To evaluate the usability of SPIRO© among family physicians and residents in family medicine working in FMU in Quebec affiliated with Laval University. Methods: This is a pre-post clinical trial with control group. Participants (family MD and family medicine residents) will be recruited from the various FMU affiliated with Laval University. Participants working in the FMU in the experimental group will be able to use the SPIRO® mobile application to facilitate interpretation of the spirometry test results while participants in the control group will not have access to it during the study. The basic characteristics of the participants and various behavioral parameters based on the theory of planned behavior concerning the interpretation and prescription of spirometry test will be measured. Data from the control group will be collected before those in the experimental group at the time the application is not yet available, which will minimize contamination between groups. The data will be collected with questionnaires delivered in person to the participants before the intervention (T0 time) and then four months later (T1 time) during their team or research meeting. Participants will be recruited in eight of the 12 Quebec FMU affiliated with Laval University, who will be randomly assigned to two equal groups: control and experimental. The intervention will consist in sending the SPIRO© mobile application to participants in the experimental group who will use it for a period of four months.

Conditions

COPD; Spirometry; Mobile Application

Keywords

COPD; Spirometry; Mobile application

Outcome Measures

Primary Outcomes (1)

• Beliefs about capabilities - interpretation

  The beliefs about the capabilities of primary care physicians and residents in family medicine regarding interpretation of spirometry.

  six weeks

Secondary Outcomes (14)

• Beliefs about consequences - prescription

  six weeks

• Beliefs about consequences - interpretation

  six weeks

• Beliefs about consequences - use of a mobile application

  six weeks

• Moral norms - prescription

  six weeks

• Moral norms - interpretation

  six weeks

Study Arms (2)

Control Group

Primary care physicians and residents in family medicine of family medicine units affiliated with Laval University.

Experimental Group

Primary care physicians and residents in family medicine of family medicine units affiliated with Laval University that will use the mobile application SPIRO(c) for a period of four months.

Device: SPIRO

Interventions

SPIRO DEVICE

Participants in the Experimental Group will be asked to use SPIRO mobile application during a period of 4 months.

Experimental Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Primary care physicians and residents in family medicine of 18 years old or more working in one of the 12 family medicine units in Quebec affiliated with Laval University.

You may qualify if:

• Participants need to be primary care physicians or residents in family medicine of 18 years old or more working in one of the 12 family medicine units in Quebec affiliated with Laval University.

You may not qualify if:

• Health professionals not practicing family medicine and residents of other specialties will not be eligible. Individuals who participated in the development of the " subjective Norms, Attitudes, Perceived behavioral control, Intentions (NAPI) " questionnaires (apparent validation) will be excluded.

Sponsors & Collaborators

• Laval University: lead

Study Sites (8)

UMF de Manicouagan

Baie-Comeau, Quebec, G4Z 3B8, Canada

Location

UMF de Gaspé

Gaspé, Quebec, G4X 2W2, Canada

Location

UMF des Etchemins

Lac-Etchemin, Quebec, G0R 1S0, Canada

Location

UMF de Lévis

Lévis, Quebec, G6W 0J4, Canada

Location

Unité de médecine familiale - GMF Maizerets

Québec, Quebec, G1J 2G1, Canada

Location

UMF Saint-François d'Assise

Québec, Quebec, G1L 3L5, Canada

Location

Unité de médecine familiale Laval

Québec, Quebec, G1V 0B7, Canada

Location

UMF de Trois-Pistoles

Trois Pistoles, Quebec, G0L 4K0, Canada

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Louis-Philippe Boulet, MD

  Heart and Lung Institute

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Pneumologist

Study Record Dates

• First Submitted: June 26, 2017
• First Posted: July 2, 2017
• Study Start: October 1, 2016
• Primary Completion: July 7, 2017
• Study Completion: December 20, 2017
• Last Updated: October 12, 2020

Record last verified: 2020-10

Locations

CA (8)